showed that the activation of monocyte surface receptors TLR1 and TLR2 in patients with RA mediated the increase in the levels of IL-6 and TNF-α, and the activation of TLR5 mediated the increase in the levels of IL-6 and IL-10. The gene discussed is TLR2; the disease is rheumatoid arthritis.